Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.23881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Junhao Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, Central Laboratory and Precision Medicine Center, Affiliated Jinhua Hospital, Zhejiang University School of …. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cisplatin, Glutamine, Serine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: This work was supported by the Natural Science Foundation of China (82373354); Zhejiang Medical and Health Science and Technology Project (2024KY502); Jinhua S….
Abstract (Originalsprache)
Gastric cancer is a common digestive system tumor with a high resistance rate that reduces the sensitivity to chemotherapy. Nutrition therapy is an important adjuvant approach to favor the prognosis of gastric cancer. Dietary amino acids contribute greatly to gastric cancer progression by mediating tumor gene expressions, epigenetics, signal transduction, and metabolic remodeling. In the present study, 20 types of amino acids were screened and glutamine, glycine and serine were identified as the critical regulators of cisplatin (DDP) sensitivity in gastric cancer cells. Moreover, KDM4A acetylation drove the reduced chemotherapy sensitivity in gastric cancer cells by maintaining protein stability and activating DNA repair ability when the concentrations of glutamine (Gln), serine (Ser), and glycine (Gly) decreased. Conversely, Gln/Ser/Gly at increasing concentrations stimulated ubiquitination degradation of KDM4A, which in turn elevated the sensitivity of gastric cancer cells to chemotherapy. Our findings unveiled the role of amino acid nutrition in regulating chemotherapy sensitivity of gastric cancer and the underlying mechanism, thus providing a scientific basis for expanding the clinical significance of nutrition therapy for gastric cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Oncology, Central Laboratory and Precision Medicine Center, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
- Department of Gastrointestinal Oncology, Jinhua Key Laboratory of Cancer Nutrition and Metabolism Research, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
- Department of Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
- Department of Experimental Technology, Dian Diagnostics Group Co. Ltd., Hangzhou, Zhejiang Province, China.
- Department of General Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
Förderung
- This work was supported by the Natural Science Foundation of China (82373354); Zhejiang Medical and Health Science and Technology Project (2024KY502); Jinhua S…
Zitieren
APA
Fu, J., Ni, Y., Hu, Y., Tang, W., Fu, J., Wang, Y., Yu, S., & Xu, W. (2025). Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23881
Vancouver
Fu J, Ni Y, Hu Y, Tang W, Fu J, Wang Y, et al. Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23881
BibTeX
@article{Fu2025,
author = {Fu, Junhao and Ni, Yuqi and Hu, Yuqing and Tang, Wanfen and Fu, Jianfei and Wang, Yue and Yu, Shian and Xu, Wenxia},
title = {Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.23881}
}
EUVIMED